|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robinson KW and Sandler AB: The role of
MET receptor tyrosine kinase in non-small cell lung cancer and
clinical development of targeted anti-MET agents. Oncologist.
18:115–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spira A and Ettinger DS: Multidisciplinary
management of lung cancer. N Engl J Med. 350:379–392. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu Q, Chen YF, Fu J, You QH, Wang SM,
Huang X, Feng XJ and Zhang SH: Short hairpin RNA-mediated
down-regulation of CENP-A attenuates the aggressive phenotype of
lung adenocarcinoma cells. Cell Oncol (Dordr). 37:399–407. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Marinis F, Bria E, Baas P, Tiseo M,
Camerini A, Favaretto AG and Gridelli C: Treatment of unfit
patients with advanced non-small-cell lung cancer: Definition
criteria according an expert panel. Clin Lung Cancer. 16:399–405.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bichev SN, Marinova DM, Slavova YG and
Savov AS: Epidermal growth factor receptor mutations in East
European non-small cell lung cancer patients. Cell Oncol (Dordr).
38:145–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhong C, Ding S, Xu Y and Huang H:
MicroRNA-222 promotes human non-small cell lung cancer H460 growth
by targeting p27. Int J Clin Exp Med. 8:5534–5540. 2015.PubMed/NCBI
|
|
9
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
10
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Donadeu FX, Schauer SN and Sontakke SD:
Involvement of miRNAs in ovarian follicular and luteal development.
J Endocrinol. 215:323–334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liwak U, Faye MD and Holcik M: Translation
control in apoptosis. Exp Oncol. 34:218–230. 2012.PubMed/NCBI
|
|
14
|
Rutnam ZJ and Yang BB: The involvement of
microRNAs in malignant transformation. Histol Histopathol.
27:1263–1270. 2012.PubMed/NCBI
|
|
15
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen L, Zhang F, Sheng XG, Zhang SQ, Chen
YT and Liu BW: MicroRNA-106a regulates phosphatase and tensin
homologue expression and promotes the proliferation and invasion of
ovarian cancer cells. Oncol Rep. 36:2135–2141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeng Y, Fu M, Wu GW, Zhang AZ, Chen JP,
Lin HY, Fu YA, Jia J, Cai ZD, Wu XJ and Lan P: Upregulation of
microRNA-370 promotes cell apoptosis and inhibits proliferation by
targeting PTEN in human gastric cancer. Int J Oncol. 49:1589–1599.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lanford RE, Hildebrandt-Eriksen ES, Petri
A, Persson R, Lindow M, Munk ME, Kauppinen S and Ørum H:
Therapeutic silencing of microRNA-122 in primates with chronic
hepatitis C virus infection. Science. 327:198–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trang P, Medina PP, Wiggins JF, Ruffino L,
Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB and
Slack FJ: Regression of murine lung tumors by the let-7 microRNA.
Oncogene. 29:1580–1587. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Rooij E, Sutherland LB, Qi X,
Richardson JA, Hill J and Olson EN: Control of stress-dependent
cardiac growth and gene expression by a microRNA. Science.
316:575–579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Montgomery RL, Hullinger TG, Semus HM,
Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN and
van Rooij E: Therapeutic inhibition of miR-208a improves cardiac
function and survival during heart failure. Circulation.
124:1537–1547. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
25
|
Cortinovis D, Monica V, Pietrantonio F,
Ceresoli GL, La Spina CM and Wannesson L: MicroRNAs in non-small
cell lung cancer: Current status and future therapeutic promises.
Curr Pharm Des. 20:3982–3990. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vannini I, Fanini F and Fabbri M:
MicroRNAs as lung cancer biomarkers and key players in lung
carcinogenesis. Clin Biochem. 46:918–925. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boeri M, Pastorino U and Sozzi G: Role of
microRNAs in lung cancer: microRNA signatures in cancer prognosis.
Cancer J. 18:268–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lei L, Huang Y and Gong W: miR-205
promotes the growth, metastasis and chemoresistance of NSCLC cells
by targeting PTEN. Oncol Rep. 30:2897–2902. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan Y, Shen Y, Xue L and Fan H: miR-140
suppresses tumor growth and metastasis of non-small cell lung
cancer by targeting insulin-like growth factor 1 receptor. PLoS
One. 8:e736042013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL,
Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, et al: Loss of
heterozygosity and its correlation with clinical outcome and
Epstein-Barr virus infection in nasopharyngeal carcinoma.
Anticancer Res. 21:3021–3029. 2001.PubMed/NCBI
|
|
31
|
Wang Y, Xu P, Yao J, Yang R, Shi Z, Zhu X,
Feng X and Gao S: MicroRNA-216b is down-regulated in human gastric
adenocarcinoma and inhibits proliferation and cell cycle
progression by targeting oncogene HDAC8. Target Oncol. 11:197–207.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu FY, Zhou SJ, Deng YL, Zhang ZY, Zhang
EL, Wu ZB, Huang ZY and Chen XP: MiR-216b is involved in
pathogenesis and progression of hepatocellular carcinoma through
HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis.
6:e16702015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zheng L, Zhang X, Yang F, Zhu J, Zhou P,
Yu F, Hou L, Xiao L, He Q and Wang B: Regulation of the P2X7R by
microRNA-216b in human breast cancer. Biochem Biophys Res Commun.
452:197–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Deng M, Liu JF, Gu YX, Zheng GP and He ZM:
miR-216b suppresses cell proliferation and invasion by targeting
PKCα in nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi.
35:645–650. 2013.(In Chinese). PubMed/NCBI
|
|
36
|
Wang H, Leav I, Ibaragi S, Wegner M, Hu
GF, Lu ML, Balk SP and Yuan X: SOX9 is expressed in human fetal
prostate epithelium and enhances prostate cancer invasion. Cancer
Res. 68:1625–1630. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Muller P, Crofts JD, Newman BS,
Bridgewater LC, Lin CY, Gustafsson JA and Ström A: SOX9 mediates
the retinoic acid-induced HES-1 gene expression in human breast
cancer cells. Breast Cancer Res Treat. 120:317–326. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bruun J, Kolberg M, Nesland JM, Svindland
A, Nesbakken A and Lothe RA: Prognostic significance of β-Catenin,
E-Cadherin and SOX9 in colorectal cancer: Results from a Large
population-representative series. Front Oncol. 4:1182014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou CH, Ye LP, Ye SX, Li Y, Zhang XY, Xu
XY and Gong LY: Clinical significance of SOX9 in human non-small
cell lung cancer progression and overall patient survival. J Exp
Clin Cancer Res. 31:182012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang X, Ju Y, Zhou MI, Liu X and Zhou C:
Upregulation of SOX9 promotes cell proliferation, migration and
invasion in lung adenocarcinoma. Oncol Lett. 10:990–994. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li J, Wang L, Liu Z, Zu C, Xing F, Yang P,
Yang Y, Dang X and Wang K: MicroRNA-494 inhibits cell proliferation
and invasion of chondrosarcoma cells in vivo and in vitro by
directly targeting SOX9. Oncotarget. 6:26216–26229. 2015.PubMed/NCBI
|
|
42
|
Rani SB, Rathod SS, Karthik S, Kaur N,
Muzumdar D and Shiras AS: MiR-145 functions as a tumor-suppressive
RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro
Oncol. 15:1302–1316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yu CC, Tsai LL, Wang ML, Yu CH, Lo WL,
Chang YC, Chiou GY, Chou MY and Chiou SH: miR145 targets the
SOX9/ADAM17 axis to inhibit tumor-initiating cells and
IL-6-mediated paracrine effects in head and neck cancer. Cancer
Res. 73:3425–3440. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang YJ, Xu F, Zhang YJ, Li HB, Han JC
and Li L: miR-206 inhibits non small cell lung cancer cell
proliferation and invasion by targeting SOX9. Int J Clin Exp Med.
8:9107–9113. 2015.PubMed/NCBI
|
|
45
|
Zhu D, Chen H, Yang X, Chen W, Wang L, Xu
J and Yu L: miR-32 functions as a tumor suppressor and directly
targets SOX9 in human non-small cell lung cancer. Onco Targets
Ther. 8:1773–1783. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu JQ, Zhang WB, Wan R and Yang YQ:
MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion
by targeting Sox9. Tumour Biol. 35:9847–9853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li Q, Yao Y, Eades G, Liu Z, Zhang Y and
Zhou Q: Downregulation of miR-140 promotes cancer stem cell
formation in basal-like early stage breast cancer. Oncogene.
33:2589–2600. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang Y, Guo X, Xiong L, Kong X, Xu Y, Liu
C, Zou L, Li Z, Zhao J and Lin N: MicroRNA-101 suppresses
SOX9-dependent tumorigenicity and promotes favorable prognosis of
human hepatocellular carcinoma. FEBS Lett. 586:4362–4370. 2012.
View Article : Google Scholar : PubMed/NCBI
|
